Application Note: MammaPrint and BluePrint in Early Breast Cancer: Clinical Implications of Prognostic Stratification and Molecular Subtyping
19 December 2013

This poster describes a study to compare tumor subtyping methods of clinical immunohistochemistry (IHC)/fluorescent insitu (FISH) hybridization, and MammaPrint and BluePrint and to determine which method of subtyping most accurately predicts long term outcome.

Download PDF >>PDF Icon

Read the full article...

  Become a member
  • Quick and complete access to all application articles

  • Download 10,000+
    applications and methods

  • Make informed buying decisions


Already a member?

Log in for full access to the article




Remember me

Company